Extracorporeal Shock Wave Therapy Is Effective in the Treatment of Bone Marrow Edema of the Medial Compartment of the Knee: A Comparative Study.
Valerio Sansone, Pietro Romeo, Vito Lavanga
https://pubmed.ncbi.nlm.nih.gov/27784022/Actively Recruiting
Led by Dokuz Eylul University · Updated on 2026-10-22
24
Participants Needed
1
Research Sites
4 weeks
Total Duration
Bone marrow edema BME is a condition seen on MRI that shows increased fluid and changes within bone marrow, often affecting weight-bearing joints like the knee. It commonly occurs in patients with knee osteoarthritis OA and is linked to pain, reduced joint function, and worsening joint damage. Recognizing and treating BME may be important for managing knee OA. This trial evaluates extracorporeal shock wave therapy ESWT as an additional treatment for knee OA patients with BME. Participants will be randomly assigned to receive either active radial ESWT or sham ESWT once a week for five weeks. Both groups will continue standard conservative treatment, including reduced weight-bearing, use of assistive devices, and pain management with paracetamol as needed. ESWT involves delivering shock waves over the affected bone area identified by MRI, while sham treatment mimics the procedure without therapeutic shock waves. The study is designed to compare effects on pain, function, patient satisfaction, and changes in BME volume on MRI. During the study, participants will have assessments at baseline, immediately after treatment, and at 4 and 8 weeks post-treatment. Pain will be measured using a visual analog scale, and function by the WOMAC index. MRI scans will assess BME volume before treatment and eight weeks after completing therapy. Patient satisfaction and paracetamol use will also be recorded. The trial aims to determine whether adding ESWT to standard care improves clinical and imaging outcomes over 13 weeks.
CONDITIONS
Extracorporeal Shock Wave Therapy in the Treatment of Periarticular Bone Marrow Edema in Patients With Knee Osteoarthritis
T
Tugba Sahin, MD
N
Nihan Erdinc Gunduz, Ass. Prof. MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Dokuz Eylul University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 5 weeks
Participants receive either active radial extracorporeal shock wave therapy or sham therapy once weekly for five weeks while continuing standard conservative treatment for bone marrow edema of the knee.
5 weekly visits
Duration - 8 weeks
Participants are monitored for eight weeks after treatment completion to evaluate pain, function, patient satisfaction, and changes in bone marrow edema volume using MRI.
3 visits at weeks 9 and 13
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Valerio Sansone, Pietro Romeo, Vito Lavanga
https://pubmed.ncbi.nlm.nih.gov/27784022/Fuqiang Gao, Wei Sun, Zirong Li...
https://pubmed.ncbi.nlm.nih.gov/26637992/Shuhua Kang, Fuqiang Gao, Jun Han...
https://pubmed.ncbi.nlm.nih.gov/29384878/Dokuz Eylul University
Lead Sponsor